Case Studies

Atrial fibrillation (AFib), the most common heart rhythm disorder, continues to rise globally - it is predicted to affect more than 12 million people in the US by 2030 and almost 18 million people in Europe by 2060. With a growing aging population and an increased prevalence of heart disease, the demand for effective treatments for AFib is higher than ever before. 

Nearly 120 million adults in the United States have hypertension, and just 1 in 4 of them have it under control. Treatments remain limited outside of lifestyle changes and hypertensive medications that are not always effective.  

Many if not most healthcare AI vendors market tweaked versions of large language models developed by other, usually larger companies. The lack of originality isn’t just a superficial concern. It may burden adopting healthcare organizations with practical, clinical and even legal risks. For clients of the radiology technology company CIVIE, formerly known as Collaborative Imaging, those worries are soon to be things of the past. 

The technologies and tools of the cardiac catheterization lab have evolved in recent years, allowing interventionalists to perform procedures with more precision than ever. Angiographic imaging, meanwhile, has remained relatively consistent—but that is all starting to change.

If explosive growth is a sure sign of astute planning, Sol Radiology has some of the best strategists in the business. As recently as late 2022, the Southern California practice had three radiologists serving one hospital. Today it’s a 45-physician force reading for 25 sites and running three of its own imaging centers. 

Dhruv Chopra started his career in radiology as a courier for a small practice. His duties included shuttling imaging orders, CDs and radiology reports between the practice, referrers and client imaging centers. He learned to endure city traffic jams like a street-hardened cabbie. Today he’s chief executive officer of a thriving company delivering high-tech solutions to radiology practices of all sizes. 

Looking to improve the efficiency of your radiology workflow? Download the latest eBook from Bayer to see how you can use AI to work smarter, not harder! You’ll gain an understanding of the workflow in radiology operations, insights on how to use AI at each step, and more. Get the eBook now!

Looking to improve the efficiency of your radiology workflow? Download the latest eBook from Bayer to see how you can use AI to work smarter, not harder! You’ll gain an understanding of the workflow in radiology operations, insights on how to use AI at each step, and more. Get the eBook now!

The late-breaking five-year results of the Evolut Low-Risk Trial presented at ACC.25 showed positive results for the Evolut TAVR system when compared to SAVR.

As coronary CT angiography (CCTA) continues its rapid expansion, scanner vendors are now offering more economical solutions to ensure access to imaging technology beyond premium systems most often only found at flagship hospitals and academic centers. To conquer CCTA’s technical challenges, new technologies and AI are being incorporated into a new scanner to simplify acquisition and consistently improve image quality. 

Exposure to scatter radiation and orthopedic issues related to years of wearing lead aprons during long EP procedures has led electrophysiologists to seek out new ways to reduce the need for angiographic X-ray.

Advancements in radiofrequency (RF) catheter ablation technology have been incremental over the past 30 years in efforts to improve safety, procedural efficiency and patient outcomes. While some newer technologies have gained a lot of attention in electrophysiology (EP) over the past several years, RF remains the solid frontline treatment.